Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Skovsgaard

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Biochemical Pharmacology|June 17, 2000
Characterisation of non-P-glycoprotein multidrug-resistant Ehrlich ascites tumour cells selected for resistance to mitoxantroneD Nielsen, J Eriksen, C Maare, et al.
British Journal of Cancer|December 1, 1989
Inhibition of vincristine binding to plasma membrane vesicles from daunorubicin-resistant Ehrlich ascites cells by multidrug resistance modulatorsM Sehested, P B Jensen, T Skovsgaard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1991
Phase II studies of 4'-iodo-4'-deoxydoxorubicin in advanced non-small cell lung, colon and breast cancersC Sessa, F Calabresi, F Cavalli, et al.
Biochimica Et Biophysica Acta|August 6, 1999
In vivo electroporation of skeletal muscle: threshold, efficacy and relation to electric field distributionJ Gehl, T H Sorensen, K Nielsen, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1997
Carcino-embryonic antigen in monitoring the growth of human colon adenocarcinoma tumour cells SK-CO-1 and HT-29 in vitro and in nude miceG Sölétormos, J M Fogh, B Sehested-Hansen, et al.
British Journal of Cancer|December 1, 1989
In vitro evaluation of the potential of aclarubicin in the treatment of small cell carcinoma of the lung (SCCL)P B Jensen, L Vindeløv, H Roed, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Antitumor activity of the two epipodophyllotoxin derivatives VP-16 and VM-26 in preclinical systems: a comparison of in vitro and in vivo drug evaluationP B Jensen, H Roed, T Skovsgaard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1990
Phase II trial with Brequinar (DUP-785, NSC 368390) in patients with metastatic colorectal cancer: a study of the Early Clinical Trials Group of the EORTCP F Dodion, T Wagener, G Stoter, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 8, 2001
A phase II study of oral eniluracil/fluorouracil in patients with anthracycline-refractory or anthracycline- and taxane-refractory advanced breast cancerT Skovsgaard, N G Davidson, M J Piccart, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 28, 2002
Irinotecan combined with bolus 5-fluorouracil and folinic acid Nordic schedule as first-line therapy in advanced colorectal cancerB Glimelius, R Ristamäki, M Kjaer, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Biochemical Pharmacology|June 17, 2000
Characterisation of non-P-glycoprotein multidrug-resistant Ehrlich ascites tumour cells selected for resistance to mitoxantroneD Nielsen, J Eriksen, C Maare, et al.
British Journal of Cancer|December 1, 1989
Inhibition of vincristine binding to plasma membrane vesicles from daunorubicin-resistant Ehrlich ascites cells by multidrug resistance modulatorsM Sehested, P B Jensen, T Skovsgaard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1991
Phase II studies of 4'-iodo-4'-deoxydoxorubicin in advanced non-small cell lung, colon and breast cancersC Sessa, F Calabresi, F Cavalli, et al.
Biochimica Et Biophysica Acta|August 6, 1999
In vivo electroporation of skeletal muscle: threshold, efficacy and relation to electric field distributionJ Gehl, T H Sorensen, K Nielsen, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1997
Carcino-embryonic antigen in monitoring the growth of human colon adenocarcinoma tumour cells SK-CO-1 and HT-29 in vitro and in nude miceG Sölétormos, J M Fogh, B Sehested-Hansen, et al.
British Journal of Cancer|December 1, 1989
In vitro evaluation of the potential of aclarubicin in the treatment of small cell carcinoma of the lung (SCCL)P B Jensen, L Vindeløv, H Roed, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Antitumor activity of the two epipodophyllotoxin derivatives VP-16 and VM-26 in preclinical systems: a comparison of in vitro and in vivo drug evaluationP B Jensen, H Roed, T Skovsgaard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1990
Phase II trial with Brequinar (DUP-785, NSC 368390) in patients with metastatic colorectal cancer: a study of the Early Clinical Trials Group of the EORTCP F Dodion, T Wagener, G Stoter, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 8, 2001
A phase II study of oral eniluracil/fluorouracil in patients with anthracycline-refractory or anthracycline- and taxane-refractory advanced breast cancerT Skovsgaard, N G Davidson, M J Piccart, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 28, 2002
Irinotecan combined with bolus 5-fluorouracil and folinic acid Nordic schedule as first-line therapy in advanced colorectal cancerB Glimelius, R Ristamäki, M Kjaer, et al.
Pageof 8